Bottom line
SMOT vs CSMD: the short answer
SMOT (VanEck Morningstar SMID Moat ETF) and CSMD (Congress SMid Growth ETF) are both etfs.
But SMOT is far broader, holding 110 positions to 47 for CSMD, so beyond the top names it adds exposure CSMD doesn't have.
SMOT is cheaper at 0.49% vs 0.68% — a difference of $19 a year per $10,000 invested.
Over one year, SMOT returned +6.5% vs +5.7% for CSMD.
Updated Nov 19, 2026
SMOT vs CSMD side by side
| SMOT | CSMD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | Tortoise |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.49% | 0.68% |
| Annual cost per $10k | $49 | $68 |
| 10-yr cost on $10k (prospectus) | $616 | $847 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +6.5% | +5.7% |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +11.5% | +12.5% |
| Worst quarter | −6.3% | −7.3% |
| Net assets (fund) | $334.4M | $454.1M |
| Number of holdings | 110 | 47 |
| Portfolio turnover | 77% | 23% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SMOT | CSMD | Difference |
|---|---|---|---|
| 2025 | +6.5% | +5.7% | +0.8% |
| 2024 | +10.8% | +12.1% | −1.3% |
Source: Fund prospectus bar charts
Holdings overlap
SMOT and CSMD share none of their top holdings.
SMOT top 10
- Acuity Inc — 1.70%
- Bio-Techne Corp — 1.66%
- Masco Corp — 1.56%
- Biogen Inc — 1.45%
- Royalty Pharma PLC — 1.45%
- Block Inc — 1.42%
- Corteva Inc — 1.42%
- Amcor PLC — 1.39%
- Gentex Corp — 1.39%
- Norwegian Cruise Line Holdings Ltd — 1.38%
CSMD top 10
- Curtiss-Wright Corp — 4.23%
- nVent Electric PLC — 3.62%
- Carpenter Technology Corp — 3.49%
- Valmont Industries Inc — 3.47%
- Rubrik Inc — 3.35%
- Halozyme Therapeutics Inc — 2.87%
- BJ's Wholesale Club Holdings I — 2.80%
- Repligen Corp — 2.78%
- Medpace Holdings Inc — 2.78%
- Rambus Inc — 2.72%
FAQ
What is the difference between SMOT and CSMD?
Which is cheaper, SMOT or CSMD?
Should I own both SMOT and CSMD?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.